vorinostat has been researched along with Subarachnoid Hemorrhage in 2 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Subarachnoid Hemorrhage: Bleeding into the intracranial or spinal SUBARACHNOID SPACE, most resulting from INTRACRANIAL ANEURYSM rupture. It can occur after traumatic injuries (SUBARACHNOID HEMORRHAGE, TRAUMATIC). Clinical features include HEADACHE; NAUSEA; VOMITING, nuchal rigidity, variable neurological deficits and reduced mental status.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Luo, K | 1 |
Wang, Z | 1 |
Zhuang, K | 1 |
Yuan, S | 1 |
Liu, F | 1 |
Liu, A | 1 |
Lu, J | 1 |
Huang, X | 1 |
Deng, A | 1 |
Yao, H | 1 |
Wu, G | 1 |
Wang, N | 1 |
Gui, H | 1 |
Ren, M | 1 |
Guo, S | 1 |
2 other studies available for vorinostat and Subarachnoid Hemorrhage
Article | Year |
---|---|
Suberoylanilide hydroxamic acid suppresses axonal damage and neurological dysfunction after subarachnoid hemorrhage via the HDAC1/HSP70/TDP-43 axis.
Topics: Animals; Apoptosis; DNA-Binding Proteins; Histone Deacetylase 1; Histone Deacetylase Inhibitors; HSP | 2022 |
miR-452-3p Targets HDAC3 to Inhibit p65 Deacetylation and Activate the NF-κB Signaling Pathway in Early Brain Injury after Subarachnoid Hemorrhage.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Brain Injuries; Histone Deacetylases; Lactate Dehydrog | 2022 |